132 related articles for article (PubMed ID: 32665674)
1. Improved detection of sinusoidal obstructive syndrome using pediatric-AYA diagnostic criteria and severity grading.
Ragoonanan D; Khazal SJ; Wang J; Payne A; Kohorst M; Harden A; Tewari P; Petropoulos D; Shoberu B; Kebriaei P; Mahadeo KM; Tambaro FP
Bone Marrow Transplant; 2021 Jan; 56(1):175-184. PubMed ID: 32665674
[TBL] [Abstract][Full Text] [Related]
2. Incidence of Anicteric Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Outcomes with Defibrotide following Hematopoietic Cell Transplantation in Adult and Pediatric Patients.
Corbacioglu S; Kernan NA; Pagliuca A; Ryan RJ; Tappe W; Richardson PG
Biol Blood Marrow Transplant; 2020 Jul; 26(7):1342-1349. PubMed ID: 32200121
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement.
Mahadeo KM; Bajwa R; Abdel-Azim H; Lehmann LE; Duncan C; Zantek N; Vittorio J; Angelo J; McArthur J; Schadler K; Chan S; Tewari P; Khazal S; Auletta JJ; Choi SW; Shoberu B; Kalwak K; Harden A; Kebriaei P; Abe JI; Li S; Moffet JR; Abraham S; Tambaro FP; Kleinschmidt K; Richardson PG; Corbacioglu S;
Lancet Haematol; 2020 Jan; 7(1):e61-e72. PubMed ID: 31818728
[TBL] [Abstract][Full Text] [Related]
4. Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association-Hematopoietic Stem Cell Transplantation Group.
Faraci M; Bertaina A; Luksch R; Calore E; Lanino E; Saglio F; Prete A; Menconi M; De Simone G; Tintori V; Cesaro S; Santarone S; Orofino MG; Locatelli F; Zecca M
Biol Blood Marrow Transplant; 2019 Feb; 25(2):313-320. PubMed ID: 30266674
[TBL] [Abstract][Full Text] [Related]
5. Validation of treatment outcomes according to revised severity criteria from European Society for Blood and Marrow Transplantation (EBMT) for sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD).
Yoon JH; Yoo KH; Sung KW; Jung CW; Kim JS; Hahn SM; Kang HJ; Lee JH; Im HJ; Ahn JS; Kook H; Cho B; Lee JW
Bone Marrow Transplant; 2019 Aug; 54(8):1361-1368. PubMed ID: 30809031
[TBL] [Abstract][Full Text] [Related]
6. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation.
Corbacioglu S; Carreras E; Ansari M; Balduzzi A; Cesaro S; Dalle JH; Dignan F; Gibson B; Guengoer T; Gruhn B; Lankester A; Locatelli F; Pagliuca A; Peters C; Richardson PG; Schulz AS; Sedlacek P; Stein J; Sykora KW; Toporski J; Trigoso E; Vetteranta K; Wachowiak J; Wallhult E; Wynn R; Yaniv I; Yesilipek A; Mohty M; Bader P
Bone Marrow Transplant; 2018 Feb; 53(2):138-145. PubMed ID: 28759025
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the proposed EBMT pediatric criteria for diagnosis and severity grading of sinusoidal obstruction syndrome.
Kammersgaard MB; Kielsen K; Heilmann C; Ifversen M; Müller K
Bone Marrow Transplant; 2019 Sep; 54(9):1406-1418. PubMed ID: 30683907
[TBL] [Abstract][Full Text] [Related]
9. Burden of illness associated with sinusoidal obstruction syndrome/veno-occlusive disease in patients with hematopoietic stem cell transplantation.
Cao Z; Villa KF; Lipkin CB; Robinson SB; Nejadnik B; Dvorak CC
J Med Econ; 2017 Aug; 20(8):871-883. PubMed ID: 28562132
[TBL] [Abstract][Full Text] [Related]
10. Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study.
Colecchia A; Ravaioli F; Sessa M; Alemanni VL; Dajti E; Marasco G; Vestito A; Zagari RM; Barbato F; Arpinati M; Cavo M; Festi D; Bonifazi F
Biol Blood Marrow Transplant; 2019 May; 25(5):995-1003. PubMed ID: 30660772
[TBL] [Abstract][Full Text] [Related]
11. Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell Transplantation.
Roeker LE; Kim HT; Glotzbecker B; Nageshwar P; Nikiforow S; Koreth J; Armand P; Cutler C; Alyea EP; Antin JH; Richardson PG; Soiffer RJ; Ho VT
Biol Blood Marrow Transplant; 2019 Jan; 25(1):137-144. PubMed ID: 30081073
[TBL] [Abstract][Full Text] [Related]
12. Veno-occlusive disease in children and adolescents after hematopoietic stem cell transplantation: Did the Modified Seattle Criteria fit the characteristics of pediatric population?
Szmit Z; Gorczyńska E; Mielcarek-Siedziuk M; Ussowicz M; Owoc-Lempach J; Kałwak K
Adv Clin Exp Med; 2020 Mar; 29(3):339-344. PubMed ID: 32207590
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of pediatric patients with anicteric and late-onset sinusoidal obstruction syndrome after hematopoietic stem cell transplantation.
Inagaki J; Noguchi M; Fukano R
Pediatr Blood Cancer; 2020 Aug; 67(8):e28412. PubMed ID: 32495502
[TBL] [Abstract][Full Text] [Related]
14. Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Shore T; Iacobelli M; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ;
Biol Blood Marrow Transplant; 2017 Jun; 23(6):997-1004. PubMed ID: 28285079
[TBL] [Abstract][Full Text] [Related]
15. Analysis of risk factors for hepatic sinusoidal obstruction syndrome following allogeneic hematopoietic stem cell transplantation in pediatric patients.
Kloehn J; Brodt G; Ernst J; Gruhn B
J Cancer Res Clin Oncol; 2022 Jun; 148(6):1447-1455. PubMed ID: 34255148
[TBL] [Abstract][Full Text] [Related]
16. Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes.
Yakushijin K; Atsuta Y; Doki N; Yokota A; Kanamori H; Miyamoto T; Ohwada C; Miyamura K; Nawa Y; Kurokawa M; Mizuno I; Mori T; Onizuka M; Taguchi J; Ichinohe T; Yabe H; Morishima Y; Kato K; Suzuki R; Fukuda T
Bone Marrow Transplant; 2016 Mar; 51(3):403-9. PubMed ID: 26595082
[TBL] [Abstract][Full Text] [Related]
17. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation.
Mohty M; Malard F; Abecassis M; Aerts E; Alaskar AS; Aljurf M; Arat M; Bader P; Baron F; Bazarbachi A; Blaise D; Ciceri F; Corbacioglu S; Dalle JH; Dignan F; Fukuda T; Huynh A; Masszi T; Michallet M; Nagler A; NiChonghaile M; Okamoto S; Pagliuca A; Peters C; Petersen FB; Richardson PG; Ruutu T; Savani BN; Wallhult E; Yakoub-Agha I; Duarte RF; Carreras E
Bone Marrow Transplant; 2016 Jul; 51(7):906-12. PubMed ID: 27183098
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound in Hepatic Veno-occlusive Disease (HVOD) after Pediatric Hematopoietic Stem Cell Transplantation (HSCT): Comparison of Diagnostic Criteria Including the Pediatric Criteria of European Society for Blood and Marrow Transplantation (EBMT).
Chung H; Im SA; Kim SK
Pediatr Hematol Oncol; 2020 May; 37(4):275-287. PubMed ID: 32131664
[TBL] [Abstract][Full Text] [Related]
19. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation.
Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ
Br J Haematol; 2017 Jul; 178(1):112-118. PubMed ID: 28444784
[TBL] [Abstract][Full Text] [Related]
20. Defibrotide for Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Prophylaxis in High-Risk Adult Patients: A Single-Center Experience Study.
Picod A; Bonnin A; Battipaglia G; Giannotti F; Ruggeri A; Brissot E; Malard F; Médiavilla C; Belhocine R; Vekhoff A; Gueye MS; Lapusan S; Adaeva R; Isnard F; Legrand O; Baylatry MT; Joly AC; Labopin M; Duléry R; Mohty M
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1471-1475. PubMed ID: 29477779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
